Hayashi, N., Niikura, N., Yamauchi, H., Nakamura, S., & Ueno, N. T. (2012). Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer.
Chicago Stili AlıntıHayashi, Naoki, Naoki Niikura, Hideko Yamauchi, Seigo Nakamura, ve Naoto T. Ueno. Adding Hormonal Therapy to Chemotherapy and Trastuzumab Improves Prognosis in Patients With Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer. 2012.
MLA AlıntıHayashi, Naoki, et al. Adding Hormonal Therapy to Chemotherapy and Trastuzumab Improves Prognosis in Patients With Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer. 2012.